Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-31

FDA Approved: VOQUEZNA DUAL PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Voquezna Dual Pak, a combination of vonoprazan fumarate and amoxicillin, to treat Helicobacter pylori infection as p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VOQUEZNA DUAL PAK (Vonoprazan fumarate and amoxicillin)

Snippet

SUPPL AP for VOQUEZNA DUAL PAK (VONOPRAZAN FUMARATE AND AMOXICILLIN)